Antihyperalgesic Effects of Ethosuximide and Mibefradil, T-type Voltage Activated Calcium Channel Blockers, in a Rat Model of Postoperative Pain.
- Author:
Helen Ki SHINN
1
;
Young Deog CHA
;
Jeong Uk HAN
;
Jeong Won YOON
;
Boo Seong KIM
;
Jang Ho SONG
Author Information
- Publication Type:Original Article
- Keywords: ethosuximide; incisional pain model; mibefradil; voltage activated calcium channel
- MeSH: Animals; Calcium Channel Blockers*; Calcium Channels*; Calcium*; Ethosuximide*; Injections, Spinal; Mibefradil*; Models, Animal*; Nociceptors; Pain, Postoperative*; Plastics; Rats*; Spinal Cord
- From:The Korean Journal of Pain 2007;20(2):92-99
- CountryRepublic of Korea
- Language:Korean
- Abstract: BACKGROUND: A correlation between a T-type voltage activated calcium channel (VACC) and pain mechanism has not yet been established. The purpose of this study is to find out the effect of ethosuximide and mibefradil, representative selective T-type VACC blockers on postoperative pain using an incisional pain model of rats. METHODS: After performing a plantar incision, rats were stabilized on plastic mesh for 2 hours. Then, the rats were injected with ethosuximide or mibefradil, intraperitoneally and intrathecally. The level of withdrawal threshold to the von Frey filament near the incision site was determined and the dose response curves were obtained. RESULTS: After an intraperitoneal ethosuximide or mibefradil injection, the dose-response curve showed a dose-dependent increase of the threshold in a withdrawal reaction. After an intrathecal injection of ethosuximide, the threshold of a withdrawal reaction to mechanical stimulation increased and the increase was dose-dependent. After an intrathecal injection of mibefradil, no change occurred in either the threshold of a withdrawal reaction to mechanical stimulation or a dose-response curve. CONCLUSIONS: The T-type VACC blockers in a rat model of postoperative pain showed the antihyperalgesic effect. This effect might be due to blockade of T-type VACC, which was distributed in the peripheral nociceptors or at the supraspinal level. Further studies of the effect of T-type VACC on a pain transmission mechanism at the spinal cord level would be needed.
